RBOT

SEC source: 0001213900-23-022510 · ownership.xml · nonDerivative · entry 1

Kelly William John · CIK 0001885525 · CFO and Treasurer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 291,188

F1 · kind: The sales reported in this Form 4 were effected to cover tax withholding obligations in connection with the vesting of restricted stock units that were granted on November 23, 2021.

SEC source: 0001213900-23-022514 · ownership.xml · nonDerivative · entry 1

Morris June · CIK 0001884658 · CLO, GC and Secretary

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 310,307

F1 · kind: The sales reported in this Form 4 were effected to cover tax withholding obligations in connection with the vesting of restricted stock units that were granted on November 23, 2021.

SEC source: 0001213900-23-022509 · ownership.xml · nonDerivative · entry 1

Sachs Adam David · CIK 0001885593 · Director · President and CEO · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,202,647

F1 · kind: The sales reported in this Form 4 were effected to cover tax withholding obligations in connection with the vesting of restricted stock units that were granted on November 23, 2021.

F2 · price: This figure is the weighted average sales price of multiple trades ranging from $2.451 to $2.456 per share. The Reporting Person undertakes to provide the staff of the Securities Exchange Commission, Vicarious Surgical Inc. or any security holder of Vicarious Surgical Inc. full information about the number of shares sold at each separate price upon request.

SEC source: 0001213900-23-022511 · ownership.xml · nonDerivative · entry 1

Khalifa Sammy · CIK 0001883777 · Director · Chief Technology Officer · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 969,228

F1 · kind: The sales reported in this Form 4 were effected to cover tax withholding obligations in connection with the vesting of restricted stock units that were granted on November 23, 2021.

F2 · price: This figure is the weighted average sales price of multiple trades ranging from $2.380 to $2.3815 per share. The Reporting Person undertakes to provide the staff of the Securities Exchange Commission, Vicarious Surgical Inc. or any security holder of Vicarious Surgical Inc. full information about the number of shares sold at each separate price upon request.

SEC source: 0001213900-23-019885 · ownership.xml · nonDerivative · entry 2

Liang Philip · CIK 0001883781 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · By E15 Fund III, LP

Disclosed balance after: 415,580

F1 · kind: The Reporting Person's purchase of the Issuer's Class A common stock reported herein was matchable under Section 16(b) of the Securities Exchange Act of 1934, as amended. The Reporting Person has agreed to pay to the Issuer, upon confirmation of settlement of the transaction, the full amount of the profit realized in connection with the transaction.

F2 · ownership.nature: Shares held directly by E15 Fund III, LP. The Reporting Person, as the managing partner of E15 Fund III, LP, may be deemed to share voting and dispositive power over the shares held by E15 Fund III, LP. The Reporting Person disclaims beneficial ownership of shares held by E15 Fund III, LP, except to the extent of any pecuniary interest therein.

SEC source: 0001213900-23-019885 · ownership.xml · nonDerivative · entry 1

Liang Philip · CIK 0001883781 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · By E15 Fund III, LP

Disclosed balance after: 365,780

F1 · kind: The Reporting Person's purchase of the Issuer's Class A common stock reported herein was matchable under Section 16(b) of the Securities Exchange Act of 1934, as amended. The Reporting Person has agreed to pay to the Issuer, upon confirmation of settlement of the transaction, the full amount of the profit realized in connection with the transaction.

F2 · ownership.nature: Shares held directly by E15 Fund III, LP. The Reporting Person, as the managing partner of E15 Fund III, LP, may be deemed to share voting and dispositive power over the shares held by E15 Fund III, LP. The Reporting Person disclaims beneficial ownership of shares held by E15 Fund III, LP, except to the extent of any pecuniary interest therein.

SEC source: 0001213900-23-019257 · ownership.xml · nonDerivative · entry 1

Liang Philip · CIK 0001883781 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · By E15 Fund III, LP

Disclosed balance after: 356,480

F1 · kind: The Reporting Person's purchase of the Issuer's Class A common stock reported herein was matchable under Section 16(b) of the Securities Exchange Act of 1934, as amended. The Reporting Person has agreed to pay to the Issuer, upon confirmation of settlement of the transaction, the full amount of the profit realized in connection with the transaction.

F2 · ownership.nature: Shares held directly by E15 Fund III, LP. The Reporting Person, as the managing partner of E15 Fund III, LP, may be deemed to share voting and dispositive power over the shares held by E15 Fund III, LP. The Reporting Person disclaims beneficial ownership of shares held by E15 Fund III, LP, except to the extent of any pecuniary interest therein.

SEC source: 0001213900-23-018397 · ownership.xml · nonDerivative · entry 1

Kelly William John · CIK 0001885525 · CFO and Treasurer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 292,327

F1 · kind: The sales reported in this Form 4 were sold pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 15, 2022.

F2 · price: This figure is the weighted average sales price of multiple trades ranging from $2.64 to $2.76 per share. The Reporting Person undertakes to provide the staff of the Securities Exchange Commission, Vicarious Surgical Inc. or any security holder of Vicarious Surgical Inc. full information about the number of shares sold at each separate price upon request.

SEC source: 0001213900-23-017207 · ownership.xml · nonDerivative · entry 1

Liang Philip · CIK 0001883781 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · By E15 Fund III, LP

Disclosed balance after: 319,380

F1 · kind: The Reporting Person's purchase of the Issuer's Class A common stock reported herein was matchable under Section 16(b) of the Securities Exchange Act of 1934, as amended. The Reporting Person has agreed to pay to the Issuer, upon confirmation of settlement of the transaction, the full amount of the profit realized in connection with the transaction.

F2 · price: This figure is the weighted average purchase price of multiple transactions ranging from $2.6880 to $2.5264 per share. The Reporting Person undertakes to provide the staff of the Securities Exchange Commission, Vicarious Surgical Inc. or any security holder of Vicarious Surgical Inc. full information about the number of shares purchased at each separate price upon request.

F3 · ownership.nature: Shares held directly by E15 Fund III, LP. The Reporting Person, as the managing partner of E15 Fund III, LP, may be deemed to share voting and dispositive power over the shares held by E15 Fund III, LP. The Reporting Person disclaims beneficial ownership of shares held by E15 Fund III, LP, except to the extent of any pecuniary interest therein.

SEC source: 0001213900-23-015095 · ownership.xml · nonDerivative · entry 1

Morris June · CIK 0001884658 · CLO, GC and Secretary

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 311,433

F1 · kind: These shares were sold pursuant to a Rule 10b5-1 trading plan entered into by the Reporting Person on September 15, 2022.

F2 · price: This figure is the weighted average sales price of multiple trades ranging from $2.77 to $2.85 per share. The Reporting Person undertakes to provide the staff of the Securities Exchange Commission, Vicarious Surgical Inc. or any security holder of Vicarious Surgical Inc. full information about the number of shares sold at each separate price upon request.

SEC source: 0001213900-23-014708 · ownership.xml · nonDerivative · entry 1

Liang Philip · CIK 0001883781 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · By E15 Fund III, LP

Disclosed balance after: 289,380

F1 · kind: The Reporting Person's purchase of the Issuer's Class A common stock reported herein was matchable under Section 16(b) of the Securities Exchange Act of 1934, as amended. The Reporting Person has agreed to pay to the Issuer, upon confirmation of settlement of the transaction, the full amount of the profit realized in connection with the transaction.

F2 · price: This figure is the weighted average purchase price of multiple transactions ranging from $2.77 to $2.92 per share. The Reporting Person undertakes to provide the staff of the Securities Exchange Commission, Vicarious Surgical Inc. or any security holder of Vicarious Surgical Inc. full information about the number of shares purchased at each separate price upon request.

F3 · ownership.nature: Shares held directly by E15 Fund III, LP. The Reporting Person, as the managing partner of E15 Fund III, LP, may be deemed to share voting and dispositive power over the shares held by E15 Fund III, LP. The Reporting Person disclaims beneficial ownership of shares held by E15 Fund III, LP, except to the extent of any pecuniary interest therein.

SEC source: 0001213900-23-014153 · ownership.xml · nonDerivative · entry 1

Liang Philip · CIK 0001883781 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · By E15 Fund III, LP

Disclosed balance after: 251,880

F1 · kind: The Reporting Person's purchase of the Issuer's Class A common stock reported herein was matchable under Section 16(b) of the Securities Exchange Act of 1934, as amended. The Reporting Person has agreed to pay to the Issuer, upon confirmation of settlement of the transaction, the full amount of the profit realized in connection with the transaction.

F2 · price: This figure is the weighted average purchase price of multiple transactions ranging from $2.79 to $2.89 per share. The Reporting Person undertakes to provide the staff of the Securities Exchange Commission, Vicarious Surgical Inc. or any security holder of Vicarious Surgical Inc. full information about the number of shares purchased at each separate price upon request.

F3 · ownership.nature: Shares held directly by E15 Fund III, LP. The Reporting Person, as the managing partner of E15 Fund III, LP, may be deemed to share voting and dispositive power over the shares held by E15 Fund III, LP. The Reporting Person disclaims beneficial ownership of shares held by E15 Fund III, LP, except to the extent of any pecuniary interest therein.

SEC source: 0001213900-23-013745 · ownership.xml · nonDerivative · entry 1

Kelly William John · CIK 0001885525 · CFO and Treasurer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 297,281

F1 · kind: The sales reported in this Form 4 were effected to cover tax withholding obligations in connection with the vesting of restricted stock units that were granted on May 19, 2022.

F2 · price: This figure is the weighted average sales price of multiple trades ranging from $2.73 to $2.91 per share. The Reporting Person undertakes to provide the staff of the Securities Exchange Commission, Vicarious Surgical Inc. or any security holder of Vicarious Surgical Inc. full information about the number of shares sold at each separate price upon request.

SEC source: 0001213900-23-013744 · ownership.xml · nonDerivative · entry 1

Sachs Adam David · CIK 0001885593 · Director · President and CEO · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,206,910

F1 · kind: The sales reported in this Form 4 were effected to cover tax withholding obligations in connection with the vesting of restricted stock units that were granted on May 19, 2022.

F2 · price: This figure is the weighted average sales price of multiple trades ranging from $2.73 to $2.82 per share. The Reporting Person undertakes to provide the staff of the Securities Exchange Commission, Vicarious Surgical Inc. or any security holder of Vicarious Surgical Inc. full information about the number of shares sold at each separate price upon request.

SEC source: 0001213900-23-013746 · ownership.xml · nonDerivative · entry 1

Morris June · CIK 0001884658 · CLO, GC and Secretary

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 313,933

F1 · kind: The sales reported in this Form 4 were effected to cover tax withholding obligations in connection with the vesting of restricted stock units that were granted on May 19, 2022.

F2 · price: This figure is the weighted average sales price of multiple trades ranging from $2.73 to $2.89 per share. The Reporting Person undertakes to provide the staff of the Securities Exchange Commission, Vicarious Surgical Inc. or any security holder of Vicarious Surgical Inc. full information about the number of shares sold at each separate price upon request.

SEC source: 0001213900-23-013747 · ownership.xml · nonDerivative · entry 1

Khalifa Sammy · CIK 0001883777 · Director · Chief Technology Officer · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 972,448

F1 · kind: The sales reported in this Form 4 were effected to cover tax withholding obligations in connection with the vesting of restricted stock units that were granted on May 19, 2022.

F2 · price: This figure is the weighted average sales price of multiple trades ranging from $2.73 to $3.025 per share. The Reporting Person undertakes to provide the staff of the Securities Exchange Commission, Vicarious Surgical Inc. or any security holder of Vicarious Surgical Inc. full information about the number of shares sold at each separate price upon request.

SEC source: 0001213900-23-012313 · ownership.xml · nonDerivative · entry 1

Liang Philip · CIK 0001883781 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · By E15 Fund III, LP

Disclosed balance after: 239,380

F1 · kind: The Reporting Person's purchase of the Issuer's Class A common stock reported herein was matchable under Section 16(b) of the Securities Exchange Act of 1934, as amended. The Reporting Person has agreed to pay to the Issuer, upon confirmation of settlement of the transaction, the full amount of the profit realized in connection with the transaction.

F2 · ownership.nature: Shares held directly by E15 Fund III, LP. The Reporting Person, as the managing partner of E15 Fund III, LP, may be deemed to share voting and dispositive power over the shares held by E15 Fund III, LP. The Reporting Person disclaims beneficial ownership of shares held by E15 Fund III, LP, except to the extent of any pecuniary interest therein.

SEC source: 0001213900-23-011558 · ownership.xml · nonDerivative · entry 1

Liang Philip · CIK 0001883781 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · By E15 Fund III, LP

Disclosed balance after: 238,180

F1 · kind: The Reporting Person's purchase of the Issuer's Class A common stock reported herein was matchable under Section 16(b) of the Securities Exchange Act of 1934, as amended. The Reporting Person has agreed to pay to the Issuer, upon confirmation of settlement of the transaction, the full amount of the profit realized in connection with the transaction.

F2 · price: This figure is the weighted average sales price of multiple trades ranging from $3.095 to $3.13 per share. The Reporting Person undertakes to provide the staff of the Securities Exchange Commission, Vicarious Surgical Inc. or any security holder of Vicarious Surgical Inc. full information about the number of shares sold at each separate price upon request.

F3 · ownership.nature: Shares held directly by E15 Fund III, LP. The Reporting Person, as the managing partner of E15 Fund III, LP, may be deemed to share voting and dispositive power over the shares held by E15 Fund III, LP. The Reporting Person disclaims beneficial ownership of shares held by E15 Fund III, LP, except to the extent of any pecuniary interest therein.

SEC source: 0001213900-23-010869 · ownership.xml · nonDerivative · entry 1

Liang Philip · CIK 0001883781 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · By E15 Fund III, LP

Disclosed balance after: 222,480

F1 · kind: The Reporting Person's purchase of the Issuer's Class A common stock reported herein was matchable under Section 16(b) of the Securities Exchange Act of 1934, as amended. The Reporting Person has agreed to pay to the Issuer, upon confirmation of settlement of the transaction, the full amount of the profit realized in connection with the transaction.

F2 · price: This figure is the weighted average sales price of multiple trades ranging from $2.944 to $3.08 per share. The Reporting Person undertakes to provide the staff of the Securities Exchange Commission, Vicarious Surgical Inc. or any security holder of Vicarious Surgical Inc. full information about the number of shares sold at each separate price upon request.

F3 · ownership.nature: Shares held directly by E15 Fund III, LP. The Reporting Person, as the managing partner of E15 Fund III, LP, may be deemed to share voting and dispositive power over the shares held by E15 Fund III, LP. The Reporting Person disclaims beneficial ownership of shares held by E15 Fund III, LP, except to the extent of any pecuniary interest therein.

SEC source: 0001213900-23-010431 · ownership.xml · nonDerivative · entry 1

Liang Philip · CIK 0001883781 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · By E15 Fund III, LP

Disclosed balance after: 162,000

F1 · kind: The Reporting Person's purchase of the Issuer's Class A common stock reported herein was matchable under Section 16(b) of the Securities Exchange Act of 1934, as amended. The Reporting Person has agreed to pay to the Issuer, upon confirmation of settlement of the transaction, the full amount of the profit realized in connection with the transaction.

F2 · price: This figure is the weighted average sales price of multiple trades ranging from $2.966 to $3.10 per share. The Reporting Person undertakes to provide the staff of the Securities Exchange Commission, Vicarious Surgical Inc. or any security holder of Vicarious Surgical Inc. full information about the number of shares sold at each separate price upon request.

F3 · ownership.nature: Shares held directly by E15 Fund III, LP. The Reporting Person, as the managing partner of E15 Fund III, LP, may be deemed to share voting and dispositive power over the shares held by E15 Fund III, LP. The Reporting Person disclaims beneficial ownership of shares held by E15 Fund III, LP, except to the extent of any pecuniary interest therein.

SEC source: 0001213900-23-009901 · ownership.xml · nonDerivative · entry 1

Liang Philip · CIK 0001883781 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · By E15 Fund III, LP

Disclosed balance after: 82,991

F1 · kind: The Reporting Person's purchase of the Issuer's Class A common stock reported herein was matchable under Section 16(b) of the Securities Exchange Act of 1934, as amended. The Reporting Person has agreed to pay to the Issuer, upon confirmation of settlement of the transaction, the full amount of the profit realized in connection with the transaction.

F2 · price: This figure is the weighted average sales price of multiple trades ranging from $3.013 to $3.10 per share. The Reporting Person undertakes to provide the staff of the Securities Exchange Commission, Vicarious Surgical Inc. or any security holder of Vicarious Surgical Inc. full information about the number of shares sold at each separate price upon request.

F3 · ownership.nature: Shares held directly by E15 Fund III, LP. The Reporting Person, as the managing partner of E15 Fund III, LP, may be deemed to share voting and dispositive power over the shares held by E15 Fund III, LP. The Reporting Person disclaims beneficial ownership of shares held by E15 Fund III, LP, except to the extent of any pecuniary interest therein.

SEC source: 0001213900-23-009200 · ownership.xml · nonDerivative · entry 1

Kelly William John · CIK 0001885525 · CFO and Treasurer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 303,568

F1 · kind: The sales reported in this Form 4 were sold pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 15, 2022.

F2 · price: This figure is the weighted average sales price of multiple trades ranging from $2.91 to $3.15 per share. The Reporting Person undertakes to provide the staff of the Securities Exchange Commission, Vicarious Surgical Inc. or any security holder of Vicarious Surgical Inc. full information about the number of shares sold at each separate price upon request.

SEC source: 0001213900-23-009493 · ownership.xml · nonDerivative · entry 1

Liang Philip · CIK 0001883781 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,218,338

F1 · kind: The Reporting Person's purchase of the Issuer's Class A common stock reported herein was matchable under Section 16(b) of the Securities Exchange Act of 1934, as amended. The Reporting Person has agreed to pay to the Issuer, upon confirmation of settlement of the transaction, the full amount of the profit realized in connection with the transaction.

F2 · price: This figure is the weighted average sales price of multiple trades ranging from $3.02 to $3.0609 per share. The Reporting Person undertakes to provide the staff of the Securities Exchange Commission, Vicarious Surgical Inc. or any security holder of Vicarious Surgical Inc. full information about the number of shares sold at each separate price upon request.

SEC source: 0001213900-23-009900 · ownership.xml · nonDerivative · entry 1

Liang Philip · CIK 0001883781 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · By E15 Fund III, LP

Disclosed balance after: 26,811

F1 · kind: The Reporting Person's purchase of the Issuer's Class A common stock reported herein was matchable under Section 16(b) of the Securities Exchange Act of 1934, as amended. The Reporting Person has agreed to pay to the Issuer, upon confirmation of settlement of the transaction, the full amount of the profit realized in connection with the transaction.

F2 · price: This figure is the weighted average sales price of multiple trades ranging from $3.02 to $3.0609 per share. The Reporting Person undertakes to provide the staff of the Securities Exchange Commission, Vicarious Surgical Inc. or any security holder of Vicarious Surgical Inc. full information about the number of shares sold at each separate price upon request.

F3 · ownership.nature: Shares held directly by E15 Fund III, LP. The Reporting Person, as the managing partner of E15 Fund III, LP, may be deemed to share voting and dispositive power over the shares held by E15 Fund III, LP. The Reporting Person disclaims beneficial ownership of shares held by E15 Fund III, LP, except to the extent of any pecuniary interest therein.

SEC source: 0001213900-23-005161 · ownership.xml · nonDerivative · entry 1

CARR BRENDEL VICTORIA · CIK 0001962858 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 108,953

F1 · shares: Consists of restricted stock units ("RSUs"). Each RSU represents the right to receive one share of Class A common stock upon vesting. The RSUs vest in equal monthly installments over three years following the date of grant, subject to the Reporting Person's continued service through the applicable vesting date.

SEC source: 0001213900-23-001343 · ownership.xml · nonDerivative · entry 1

Kelly William John · CIK 0001885525 · CFO and Treasurer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 308,704

F1 · kind: The sales reported in this Form 4 were sold pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 15, 2022.

F2 · price: This figure is the weighted average sales price of multiple trades ranging from $1.91 to $2.09 per share. The Reporting Person undertakes to provide the staff of the Securities Exchange Commission, Vicarious Surgical Inc. or any security holder of Vicarious Surgical Inc. full information about the number of shares sold at each separate price upon request.

SEC source: 0001213900-23-000861 · ownership.xml · nonDerivative · entry 1

Ho David D · CIK 0001850976 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 89,840

F1 · price: Restricted stock units ("RSUs") granted to the Reporting Person pursuant to the Issuer's Amended and Restated Non-Employee Director Compensation Policy in lieu of $11,375 of cash retainer fees earned during the fourth quarter of 2022. The RSUs were fully vested on the grant date.

SEC source: 0001213900-23-000868 · ownership.xml · nonDerivative · entry 1

Liang Philip · CIK 0001883781 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,191,527

F1 · price: Restricted stock units ("RSUs") granted to the Reporting Person pursuant to the Issuer's Amended and Restated Non-Employee Director Compensation Policy in lieu of $12,537.50 of cash retainer fees earned during the fourth quarter of 2022. The RSUs were fully vested on the grant date.

SEC source: 0001213900-22-083083 · ownership.xml · nonDerivative · entry 1

Morris June · CIK 0001884658 · CLO, GC and Secretary

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 320,151

F1 · kind: These shares were sold pursuant to a Rule 10b5-1 trading plan entered into by the Reporting Person on September 15, 2022.

F2 · price: This figure is the weighted average sales price of multiple trades ranging from $1.70 to $1.82 per share. The Reporting Person undertakes to provide the staff of the Securities Exchange Commission, Vicarious Surgical Inc. or any security holder of Vicarious Surgical Inc. full information about the number of shares sold at each separate price upon request.

SEC source: 0001213900-22-082170 · ownership.xml · nonDerivative · entry 1

Kelly William John · CIK 0001885525 · CFO and Treasurer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 313,709

F1 · kind: The sales reported in this Form 4 were effected to cover tax withholding obligations in connection with the vesting of restricted stock units that were granted on November 23, 2021.

F2 · price: This figure is the weighted average sales price of multiple trades ranging from $1.795 to $1.91 per share. The Reporting Person undertakes to provide the staff of the Securities Exchange Commission, Vicarious Surgical Inc. or any security holder of Vicarious Surgical Inc. full information about the number of shares sold at each separate price upon request.

SEC source: 0001213900-22-082166 · ownership.xml · nonDerivative · entry 1

Sachs Adam David · CIK 0001885593 · Director · President and CEO · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,230,448

F1 · kind: The sales reported in this Form 4 were effected to cover tax withholding obligations in connection with the vesting of restricted stock units that were granted on November 23, 2021.

F2 · price: This figure is the weighted average sales price of multiple trades ranging from $1.795 to $1.91 per share. The Reporting Person undertakes to provide the staff of the Securities Exchange Commission, Vicarious Surgical Inc. or any security holder of Vicarious Surgical Inc. full information about the number of shares sold at each separate price upon request.

SEC source: 0001213900-22-082172 · ownership.xml · nonDerivative · entry 1

Morris June · CIK 0001884658 · CLO, GC and Secretary

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 322,308

F1 · kind: The sales reported in this Form 4 were effected to cover tax withholding obligations in connection with the vesting of restricted stock units that were granted on November 23, 2021.

F2 · price: This figure is the weighted average sales price of multiple trades ranging from $1.80 to $1.98 per share. The Reporting Person undertakes to provide the staff of the Securities Exchange Commission, Vicarious Surgical Inc. or any security holder of Vicarious Surgical Inc. full information about the number of shares sold at each separate price upon request.

SEC source: 0001213900-22-082171 · ownership.xml · nonDerivative · entry 1

Khalifa Sammy · CIK 0001883777 · Director · Chief Technology Officer · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 991,278

F1 · kind: The sales reported in this Form 4 were effected to cover tax withholding obligations in connection with the vesting of restricted stock units that were granted on November 23, 2021.

F2 · price: This figure is the weighted average sales price of multiple trades ranging from $1.81 to $1.885 per share. The Reporting Person undertakes to provide the staff of the Securities Exchange Commission, Vicarious Surgical Inc. or any security holder of Vicarious Surgical Inc. full information about the number of shares sold at each separate price upon request.

SEC source: 0001213900-22-077968 · ownership.xml · nonDerivative · entry 1

Kelly William John · CIK 0001885525 · CFO and Treasurer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 314,782

F1 · kind: The sales reported in this Form 4 were sold pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 15, 2022.

F2 · price: This figure is the weighted average sales price of multiple trades ranging from $2.92 to $3.31 per share. The Reporting Person undertakes to provide the staff of the Securities Exchange Commission, Vicarious Surgical Inc. or any security holder of Vicarious Surgical Inc. full information about the number of shares sold at each separate price upon request.

SEC source: 0001213900-22-076205 · ownership.xml · nonDerivative · entry 3

Sachs Adam David · CIK 0001885593 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,234,467

F4 · kind: These shares were sold pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 15, 2022.

F5 · price: This figure is the weighted average sales price of multiple trades ranging from $3.36 to $3.62 per share. The Reporting Person undertakes to provide the staff of the Securities Exchange Commission, Vicarious Surgical Inc. or any security holder of Vicarious Surgical Inc. full information about the number of shares sold at each separate price upon request.

SEC source: 0001213900-22-076205 · ownership.xml · nonDerivative · entry 2

Sachs Adam David · CIK 0001885593 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,242,792

F2 · kind: These shares were sold pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 15, 2022.

F3 · price: This figure is the weighted average sales price of multiple trades ranging from $3.37 to $3.48 per share. The Reporting Person undertakes to provide the staff of the Securities Exchange Commission, Vicarious Surgical Inc. or any security holder of Vicarious Surgical Inc. full information about the number of shares sold at each separate price upon request.

SEC source: 0001213900-22-076205 · ownership.xml · nonDerivative · entry 1

Sachs Adam David · CIK 0001885593 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,254,121

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each share of Class B Common Stock, par value $0.0001 per share (the "Class B Common Stock"), was converted into one share of Class A Common Stock, par value $0.0001 per share (the "Class A Common Stock"), for no additional consideration at the option of the Reporting Person. The shares of Class B Common Stock are convertible into an equal number of shares of Class A Common Stock at the Reporting Person's election and have no expiration date.

SEC source: 0001213900-22-076481 · ownership.xml · derivative · entry 1

Sachs Adam David · CIK 0001885593 · Director · President and CEO · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 11,239,063

Underlying: Class A Common Stock · 11,329 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each share of Class B Common Stock, par value $0.0001 per share (the "Class B Common Stock"), was converted into one share of Class A Common Stock, par value $0.0001 per share (the "Class A Common Stock"), for no additional consideration at the option of the Reporting Person. The shares of Class B Common Stock are convertible into an equal number of shares of Class A Common Stock at the Reporting Person's election and have no expiration date.

F2 · date: On November 30, 2022, the reporting person filed a Form 4 that mistakenly indicated an incorrect transaction date for the conversion of Class B Common Stock. The correct transaction date is 11/28/2022.

F1 · derivative.exercise_date: Each share of Class B Common Stock, par value $0.0001 per share (the "Class B Common Stock"), was converted into one share of Class A Common Stock, par value $0.0001 per share (the "Class A Common Stock"), for no additional consideration at the option of the Reporting Person. The shares of Class B Common Stock are convertible into an equal number of shares of Class A Common Stock at the Reporting Person's election and have no expiration date.

F1 · derivative.expiration_date: Each share of Class B Common Stock, par value $0.0001 per share (the "Class B Common Stock"), was converted into one share of Class A Common Stock, par value $0.0001 per share (the "Class A Common Stock"), for no additional consideration at the option of the Reporting Person. The shares of Class B Common Stock are convertible into an equal number of shares of Class A Common Stock at the Reporting Person's election and have no expiration date.

SEC source: 0001213900-22-075449 · ownership.xml · nonDerivative · entry 1

Morris June · CIK 0001884658 · CLO, GC and Secretary

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 323,369

F1 · kind: These shares were sold pursuant to a Rule 10b5-1 trading plan entered into by the Reporting Person on September 15, 2022.

F2 · price: This figure is the weighted average sales price of multiple trades ranging from $3.58 to $3.85 per share. The Reporting Person undertakes to provide the staff of the Securities Exchange Commission, Vicarious Surgical Inc. or any security holder of Vicarious Surgical Inc. full information about the number of shares sold at each separate price upon request.

SEC source: 0001213900-22-074683 · ownership.xml · nonDerivative · entry 1

Kelly William John · CIK 0001885525 · CFO and Treasurer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 319,067

F1 · kind: The sales reported in this Form 4 were effected to cover tax withholding obligations in connection with the vesting of restricted stock units that were granted on May 19, 2022.

F2 · price: This figure is the weighted average sales price of multiple trades ranging from $3.13 to $3.405 per share. The Reporting Person undertakes to provide the staff of the Securities Exchange Commission, Vicarious Surgical Inc. or any security holder of Vicarious Surgical Inc. full information about the number of shares sold at each separate price upon request.

SEC source: 0001213900-22-074649 · ownership.xml · nonDerivative · entry 1

Sachs Adam David · CIK 0001885593 · Director · President and CEO · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,242,792

F1 · kind: The sales reported in this Form 4 were effected to cover tax withholding obligations in connection with the vesting of restricted stock units that were granted on May 19, 2022.

F2 · price: This figure is the weighted average sales price of multiple trades ranging from $3.185 to $3.335 per share. The Reporting Person undertakes to provide the staff of the Securities Exchange Commission, Vicarious Surgical Inc. or any security holder of Vicarious Surgical Inc. full information about the number of shares sold at each separate price upon request.

SEC source: 0001213900-22-074686 · ownership.xml · nonDerivative · entry 1

Morris June · CIK 0001884658 · CLO, GC and Secretary

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 325,869

F1 · kind: The sales reported in this Form 4 were effected to cover tax withholding obligations in connection with the vesting of restricted stock units that were granted on May 19, 2022.

F2 · price: This figure is the weighted average sales price of multiple trades ranging from $3.13 to $3.41 per share. The Reporting Person undertakes to provide the staff of the Securities Exchange Commission, Vicarious Surgical Inc. or any security holder of Vicarious Surgical Inc. full information about the number of shares sold at each separate price upon request.

SEC source: 0001213900-22-074688 · ownership.xml · nonDerivative · entry 1

Khalifa Sammy · CIK 0001883777 · Director · Chief Technology Officer · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 994,493

F1 · kind: The sales reported in this Form 4 were effected to cover tax withholding obligations in connection with the vesting of restricted stock units that were granted on May 19, 2022.

F2 · price: This figure is the weighted average sales price of multiple trades ranging from $3.13 to $3.415 per share. The Reporting Person undertakes to provide the staff of the Securities Exchange Commission, Vicarious Surgical Inc. or any security holder of Vicarious Surgical Inc. full information about the number of shares sold at each separate price upon request.

SEC source: 0001213900-22-073112 · ownership.xml · derivative · entry 3

Khalifa Sammy · CIK 0001883777 · Director · Chief Technology Officer · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,515,260

Underlying: Class A Common Stock · 4,551 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each share of Class B Common Stock, par value $0.0001 per share (the "Class B Common Stock"), was converted into one share of Class A Common Stock, par value $0.0001 per share (the "Class A Common Stock"), for no additional consideration at the option of the Reporting Person. The shares of Class B Common Stock are convertible into an equal number of shares of Class A Common Stock at the Reporting Person's election and have no expiration date.

F1 · derivative.exercise_date: Each share of Class B Common Stock, par value $0.0001 per share (the "Class B Common Stock"), was converted into one share of Class A Common Stock, par value $0.0001 per share (the "Class A Common Stock"), for no additional consideration at the option of the Reporting Person. The shares of Class B Common Stock are convertible into an equal number of shares of Class A Common Stock at the Reporting Person's election and have no expiration date.

F1 · derivative.expiration_date: Each share of Class B Common Stock, par value $0.0001 per share (the "Class B Common Stock"), was converted into one share of Class A Common Stock, par value $0.0001 per share (the "Class A Common Stock"), for no additional consideration at the option of the Reporting Person. The shares of Class B Common Stock are convertible into an equal number of shares of Class A Common Stock at the Reporting Person's election and have no expiration date.

SEC source: 0001213900-22-073112 · ownership.xml · nonDerivative · entry 2

Khalifa Sammy · CIK 0001883777 · Director · Chief Technology Officer · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,012,534

F2 · kind: These shares were sold pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 15, 2022.

F3 · price: This figure is the weighted average sales price of multiple trades ranging from $3.57 to $3.72 per share. The Reporting Person undertakes to provide the staff of the Securities Exchange Commission, Vicarious Surgical Inc. or any security holder of Vicarious Surgical Inc. full information about the number of shares sold at each separate price upon request.

SEC source: 0001213900-22-073112 · ownership.xml · nonDerivative · entry 1

Khalifa Sammy · CIK 0001883777 · Director · Chief Technology Officer · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,017,085

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each share of Class B Common Stock, par value $0.0001 per share (the "Class B Common Stock"), was converted into one share of Class A Common Stock, par value $0.0001 per share (the "Class A Common Stock"), for no additional consideration at the option of the Reporting Person. The shares of Class B Common Stock are convertible into an equal number of shares of Class A Common Stock at the Reporting Person's election and have no expiration date.

SEC source: 0001213900-22-071896 · ownership.xml · nonDerivative · entry 1

Liang Philip · CIK 0001883781 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,185,320

F1 · price: This figure is the weighted average sales price of multiple trades ranging from $3.45 to $3.714 per share. The Reporting Person undertakes to provide the staff of the Securities Exchange Commission, Vicarious Surgical Inc. or any security holder of Vicarious Surgical Inc. full information about the number of shares sold at each separate price upon request.

SEC source: 0001213900-22-070676 · ownership.xml · nonDerivative · entry 1

Kelly William John · CIK 0001885525 · CFO and Treasurer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 325,136

F1 · kind: The sales reported in this Form 4 were sold pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 15, 2022.

F2 · price: This figure is the weighted average sales price of multiple trades ranging from $3.65 to $3.935 per share. The Reporting Person undertakes to provide the staff of the Securities Exchange Commission, Vicarious Surgical Inc. or any security holder of Vicarious Surgical Inc. full information about the number of shares sold at each separate price upon request.

SEC source: 0001213900-22-067118 · ownership.xml · derivative · entry 3

Sachs Adam David · CIK 0001885593 · Director · President and CEO · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 11,250,392

Underlying: Class A Common Stock · 11,329 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each share of Class B Common Stock, par value $0.0001 per share (the "Class B Common Stock"), was converted into one share of Class A Common Stock, par value $0.0001 per share (the "Class A Common Stock"), for no additional consideration at the option of the Reporting Person. The shares of Class B Common Stock are convertible into an equal number of shares of Class A Common Stock at the Reporting Person's election and have no expiration date.

F1 · derivative.exercise_date: Each share of Class B Common Stock, par value $0.0001 per share (the "Class B Common Stock"), was converted into one share of Class A Common Stock, par value $0.0001 per share (the "Class A Common Stock"), for no additional consideration at the option of the Reporting Person. The shares of Class B Common Stock are convertible into an equal number of shares of Class A Common Stock at the Reporting Person's election and have no expiration date.

F1 · derivative.expiration_date: Each share of Class B Common Stock, par value $0.0001 per share (the "Class B Common Stock"), was converted into one share of Class A Common Stock, par value $0.0001 per share (the "Class A Common Stock"), for no additional consideration at the option of the Reporting Person. The shares of Class B Common Stock are convertible into an equal number of shares of Class A Common Stock at the Reporting Person's election and have no expiration date.

SEC source: 0001213900-22-067118 · ownership.xml · nonDerivative · entry 2

Sachs Adam David · CIK 0001885593 · Director · President and CEO · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,265,678

F2 · kind: These shares were sold pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 15, 2022.

F3 · price: This figure is the weighted average sales price of multiple trades ranging from $3.34 to $3.53 per share. The Reporting Person undertakes to provide the staff of the Securities Exchange Commission, Vicarious Surgical Inc. or any security holder of Vicarious Surgical Inc. full information about the number of shares sold at each separate price upon request.